Last month MMV co-hosted a meeting for donors in Barcelona on the importance of partnerships in the fight against malaria, and took this opportunity to interview experts in this field on the need for sustainable financing.
How much does it cost to develop a new drug?
Dr Robert Newman
Global Malaria Programme (GMP), World Health Organization
Dr Dennis Schmatz
President and CEO
Medicines for Malaria Venture; President, MMV North America, Inc. Board; Former Vice President, Head of Tsukuba Research Institute, Merck Research Laboratories
Dr Carlos Morel
Center for Technological Development in Health, Oswaldo Cruz Foundation (FIOCRUZ); MMV Board Member